155
Views
10
CrossRef citations to date
0
Altmetric
Articles

Synthesis, crystal structure, DNA binding, cleavage and cytotxicity, antimicrobial activity of new copper(II) complex with L-ornithine and 1,10-phenanthroline

, &
Pages 269-277 | Received 30 Jan 2015, Accepted 01 May 2016, Published online: 27 Jul 2016
 

ABSTRACT

A new copper(II) complex, [Cu(phen)(L-orn)(NO3)](NO3).2(H2O) (phen = 1,10-phenanthroline, L-orn = L-ornithine), has been synthesized and structurally characterized by elemental analyses, IR, UV-visible and single-crystal XRD techniques. The complex crystallized in a monoclinic system with space group P21, a = 10.561(5) Å, b = 6.927(5) Å, c = 15.510(5) Å, α = 90.000(5)°, β = 106.827(5)°, and γ = 90.000(5)°. The complex shows a distorted square-pyramidal (4+1) CuN3O2 coordination sphere. The binding interaction of the present complex with calf-thymus DNA (CT-DNA) was investigated and proposed partial intercalation binding mode by UV-Vis, fluorescence, cyclic voltammetry, and viscometric techniques. The efficient cleavage activity of the complex on plasmid DNA by complex was observed from gel electrophoresis technique. The complex exhibited potent cytotoxic effects against human cell line (HepG2) and it was found to have good antibacterial and antifungal activities.

Acknowledgments

The authors are grateful to IIT Madras, Chennai, India, for providing instrumental facilities such as IR spectroscopy, X-ray crystallography, emission spectroscopy, and TGA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.